![]() |
Volumn 4, Issue , 2010, Pages 18-19
|
How can we target pulmonary inflammation in cystic fibrosis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANTIBIOTIC AGENT;
CATHEPSIN;
CERAMIDE;
CHLORIDE ION;
GLYCYLPROLINE;
HIGH MOBILITY GROUP B1 PROTEIN;
LEUKOCYTE ELASTASE;
MATRIX METALLOPROTEINASE;
PROLYLGLYCYLPROLINE;
SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;
SPHINGOMYELIN PHOSPHODIESTERASE;
UNCLASSIFIED DRUG;
ANTIBIOTIC THERAPY;
ANTIINFLAMMATORY ACTIVITY;
BACTERIAL INFECTION;
CHLORIDE CONDUCTANCE;
CYSTIC FIBROSIS;
DRUG DESIGN;
DRUG EFFICACY;
DRUG PROTEIN BINDING;
DRUG TARGETING;
EDITORIAL;
HUMAN;
INFECTION SENSITIVITY;
LIPID BLOOD LEVEL;
NONHUMAN;
PATHOGENESIS;
PNEUMONIA;
PRIORITY JOURNAL;
|
EID: 77953366200
PISSN: None
EISSN: 18743064
Source Type: Journal
DOI: 10.2174/1874306401004020018 Document Type: Editorial |
Times cited : (3)
|
References (6)
|